Molina Healthcare (MOH) to Release Earnings on Thursday

Molina Healthcare (NYSE:MOH) is expected to be releasing its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect Molina Healthcare to post earnings of $0.43 per share and revenue of $10.9046 billion for the quarter. Investors can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Friday, February 6, 2026 at 8:00 AM ET.

Molina Healthcare Stock Performance

Shares of Molina Healthcare stock opened at $181.17 on Tuesday. The business’s fifty day simple moving average is $171.71 and its 200 day simple moving average is $171.13. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.92. Molina Healthcare has a 12 month low of $133.40 and a 12 month high of $359.97. The firm has a market capitalization of $9.82 billion, a P/E ratio of 11.22 and a beta of 0.49.

Insider Activity at Molina Healthcare

In other news, Director Richard M. Schapiro sold 357 shares of Molina Healthcare stock in a transaction on Monday, November 24th. The stock was sold at an average price of $143.02, for a total value of $51,058.14. Following the completion of the transaction, the director directly owned 11,352 shares in the company, valued at approximately $1,623,563.04. The trade was a 3.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.26% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in MOH. AQR Capital Management LLC lifted its holdings in shares of Molina Healthcare by 217.0% in the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after buying an additional 2,008,458 shares in the last quarter. UBS Group AG increased its holdings in Molina Healthcare by 320.7% during the 3rd quarter. UBS Group AG now owns 603,934 shares of the company’s stock worth $115,569,000 after acquiring an additional 460,372 shares during the period. Viking Global Investors LP purchased a new stake in Molina Healthcare in the 2nd quarter worth approximately $79,665,000. BNP Paribas Financial Markets boosted its holdings in Molina Healthcare by 130.8% in the 3rd quarter. BNP Paribas Financial Markets now owns 269,632 shares of the company’s stock valued at $51,597,000 after purchasing an additional 152,783 shares during the period. Finally, Man Group plc grew its position in shares of Molina Healthcare by 1,551.9% during the 2nd quarter. Man Group plc now owns 127,132 shares of the company’s stock valued at $37,873,000 after purchasing an additional 119,436 shares in the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on MOH. Jefferies Financial Group set a $160.00 target price on Molina Healthcare in a research note on Tuesday, December 16th. UBS Group lowered their price objective on shares of Molina Healthcare from $180.00 to $170.00 and set a “neutral” rating on the stock in a research report on Friday, October 24th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $224.00 target price on shares of Molina Healthcare in a research note on Tuesday, January 6th. The Goldman Sachs Group lowered their price target on shares of Molina Healthcare from $207.00 to $167.00 and set a “neutral” rating on the stock in a report on Friday, October 24th. Finally, Barclays upped their price objective on Molina Healthcare from $144.00 to $164.00 and gave the company an “underweight” rating in a research note on Monday, January 5th. Three investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Molina Healthcare currently has an average rating of “Hold” and a consensus target price of $193.47.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.